BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21481985)

  • 21. A facile synthesis of novel bis-(indolyl)-1,3,4-oxadiazoles as potent cytotoxic agents.
    Kumar D; Arun V; Maruthi Kumar N; Acosta G; Noel B; Shah K
    ChemMedChem; 2012 Nov; 7(11):1915-20. PubMed ID: 22997171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Potential Biologically Active Compounds: Synthesis and Characterization of Urea and Thiourea Derivativpes Bearing 1,2,4-oxadiazole Ring.
    Ölmez NA; Waseer F
    Curr Org Synth; 2020; 17(7):525-534. PubMed ID: 32303172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents.
    Verma G; Chashoo G; Ali A; Khan MF; Akhtar W; Ali I; Akhtar M; Alam MM; Shaquiquzzaman M
    Bioorg Chem; 2018 Apr; 77():106-124. PubMed ID: 29353728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New 2-benzylsulfanyl-nicotinic acid based 1,3,4-oxadiazoles: their synthesis and biological evaluation.
    Patel NB; Purohit AC; Rajani DP; Moo-Puc R; Rivera G
    Eur J Med Chem; 2013 Apr; 62():677-87. PubMed ID: 23434641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Part II: Design, synthesis and antitumor action of C3/C3 bisfluoroquinolones linked-cross 2, 5-[1, 3, 4]oxadiazole.
    Hu GQ; Yang Y; Yi L; Wang X; Zhang ZQ; Xie SQ; Huang WL
    Yao Xue Xue Bao; 2010 Aug; 45(8):1012-6. PubMed ID: 21348428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
    Bajaj S; Roy PP; Singh J
    Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
    Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents.
    Zhang HZ; Kasibhatla S; Kuemmerle J; Kemnitzer W; Ollis-Mason K; Qiu L; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
    J Med Chem; 2005 Aug; 48(16):5215-23. PubMed ID: 16078840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Anticancer Activity of New ((Furan-2-yl)-1,3,4-thiadiazolyl)-1,3,4-oxadiazole Acyclic Sugar Derivatives.
    Kassem AF; Nassar IF; Abdel-Aal MT; Awad HM; El-Sayed WA
    Chem Pharm Bull (Tokyo); 2019; 67(8):888-895. PubMed ID: 31366838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2.
    Hamdy R; Elseginy SA; Ziedan NI; El-Sadek M; Lashin E; Jones AT; Westwell AD
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors.
    Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE
    Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticancer activity of novel 5-(indole-2-yl)-3-substituted 1,2,4-oxadiazoles.
    Wang P; Liu J; Xing H; Liu Y; Xie W; Zhao G
    Drug Discov Ther; 2012 Jun; 6(3):133-9. PubMed ID: 22890203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles.
    Ziedan NI; Stefanelli F; Fogli S; Westwell AD
    Eur J Med Chem; 2010 Oct; 45(10):4523-30. PubMed ID: 20705365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro biological evaluation of novel pyrazole derivatives as potential antitumor agents.
    Christodoulou MS; Fokialakis N; Nam S; Jove R; Skaltsounis AL; Haroutounian SA
    Med Chem; 2012 Sep; 8(5):779-88. PubMed ID: 22741785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.
    El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
    Kaneko D; Ninomiya M; Yoshikawa R; Ono Y; Sonawane AD; Tanaka K; Nishina A; Koketsu M
    Bioorg Chem; 2020 Nov; 104():104293. PubMed ID: 33010622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents.
    Hamdy R; Ziedan NI; Ali S; Bordoni C; El-Sadek M; Lashin E; Brancale A; Jones AT; Westwell AD
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1037-1040. PubMed ID: 28087272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro anti-tumor activity of new oxadiazole thioglycosides.
    Abu-Zaied MA; El-Telbani EM; Elgemeie GH; Nawwar GA
    Eur J Med Chem; 2011 Jan; 46(1):229-35. PubMed ID: 21115211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.